Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.
Rujkijyanont P, Photia A, Traivaree C, Monsereenusorn C, Anurathapan U, Seksarn P, Sosothikul D, Techavichit P, Sanpakit K, Phuakpet K, Wiangnon S, Chotsampancharoen T, Chainansamit SO, Kanjanapongkul S, Meekaewkunchorn A, Hongeng S. Rujkijyanont P, et al. Among authors: hongeng s. BMC Cancer. 2019 Oct 16;19(1):961. doi: 10.1186/s12885-019-6186-z. BMC Cancer. 2019. PMID: 31619207 Free PMC article.
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying K, Monsereenusorn C, Rujkijyanont P, Techavichit P, Phuakpet K, Pongphitcha P, Chainansamit SO, Chotsampancharoen T, Winaichatsak A, Traivaree C, Sathitsamitphong L, Kanjanapongkul S, Komvilaisak P, Sanpakit K, Photia A, Seksarn P, Wiangnon S, Hongeng S; Thai Pediatric Oncology Neuroblastoma Working Group. Suwannaying K, et al. Among authors: hongeng s. Pediatr Blood Cancer. 2022 Sep;69(9):e29757. doi: 10.1002/pbc.29757. Epub 2022 May 13. Pediatr Blood Cancer. 2022. PMID: 35560972
Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial.
Koonrungsesomboon N, Ngamphaiboon N, Townamchai N, Teeyakasem P, Charoentum C, Charoenkwan P, Natesirinilkul R, Sathitsamitphong L, Ativitavas T, Chaiyawat P, Klangjorhor J, Hongeng S, Pruksakorn D. Koonrungsesomboon N, et al. Among authors: hongeng s. BMC Cancer. 2020 Mar 30;20(1):268. doi: 10.1186/s12885-020-06751-2. BMC Cancer. 2020. PMID: 32228535 Free PMC article.
306 results